Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Metis TechBio CoHKSE:07666 +2.00%6 Pretax Margin % is -4,316.96% as of Dec. 2025. GuruFocus rates HKSE:07666 with a GF Score™ of 6/100. The stock has 1 warning sign investors should review. Among 944 Biotechnology companies, Metis TechBio Co ranks worse than 88.45% on this metric.
The historical rank and industry rank for Metis TechBio Co's Pretax Margin % or its related term are showing as below:
HKSE:07666'
s Pretax Margin % Range Over the Past 10 Years
Min: -92464.3 Med: -19960.66 Max: -373.06
Current: -4316.96
HKSE:07666's Pretax Margin % is ranked worse than 88.45% of 944
companies
in the Biotechnology industry
Industry Median: -86.365
vs HKSE:07666: -4316.96
Metis TechBio Co (HKSE:07666) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Metis TechBio Co Pretax Margin % Related Terms
Metis TechBio Co Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Metis TechBio Co's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metis TechBio Co Pretax Margin % Chart
Metis TechBio Co Annual Data
Trend
Dec22
Dec23
Dec24
Dec25
Pretax Margin %
-92,464.30
-6,231.62
-33,689.70
-373.06
Metis TechBio Co Quarterly Data
Dec22
Dec23
Dec24
Sep25
Dec25
Pretax Margin %
0.00
0.00
-27,804.67
0.00
-4,316.96
HKSE:07666 vs VRTX, REGN, RVMD: Pretax Margin % Comparison
For the Biotechnology subindustry, Metis TechBio Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metis TechBio Co Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Metis TechBio Co's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Metis TechBio Co's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metis TechBio Co (HKSE:07666) has a Pretax Margin % of -4,316.96% as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Metis TechBio Co and its competitors. According to the industry distribution chart, Metis TechBio Co ranks #835 out of 944 companies in the Biotechnology industry, placing it in the top 88.5%.
Is Metis TechBio Co's Pretax Margin % too high?
Metis TechBio Co's current Pretax Margin % is -4,316.96%. Based on the distribution chart, Metis TechBio Co ranks #835 out of 944 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Metis TechBio Co has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Metis TechBio Co's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Metis TechBio Co ranks #835 out of 944 companies for Pretax Margin %. This places Metis TechBio Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Metis TechBio Co and its competitors. Metis TechBio Co's current Pretax Margin % is -4,316.96%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metis TechBio Co stock overvalued right now?
Metis TechBio Co (HKSE:07666) has a current Pretax Margin % of -4,316.96%. The current Pretax Margin % is -4,316.96%. Metis TechBio Co's overall GF Score™ is 6/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Metis TechBio Co (HKSE:07666), the current Pretax Margin % is -4,316.96% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Metis TechBio Co Ltd is an investment holding company. The company and its subsidiaries are principally engaged in AI-empowered nanomaterial innovation for the delivery and application of active agents across all carbon-based life forms. Its technology platform, NanoForge, comprises a set of integrated tools, including a lipid library, AI models, an AI agent (METiS), quantum chemistry and molecular dynamics simulations, and high-throughput screening platforms. The company has developed three solution platforms (AiTEM, AiLNP, and AiRNA) designed to simulate, predict, and interpret nanoscale interactions, enabling the rational design, optimization, and validation of nanomaterials and their associated payloads.
6GF Score
Get the complete analysis for HKSE:07666
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:07666 has been successfully added to your 
